Detalhe da pesquisa
1.
Genotypic resistance testing improves antiretroviral treatment outcomes in a cohort of adolescents in Cameroon: Implications in the dolutegravir-era.
J Public Health Afr
; 14(10): 2612, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020274
2.
HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
PLoS One
; 18(10): e0293326, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37878637